FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/081517 [Registered on: 03/03/2025] Trial Registered Prospectively
Last Modified On: 03/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Vijaya Herbal Patch for Post-Surgery Pain 
Scientific Title of Study   Development And Evaluation Of Clinical Efficacy Of Vijaya Patra Transdermal Patch In Post Operative Pain Management  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nikhil Nimba Girase 
Designation  PG Scholar 
Affiliation  Parul Institute of Ayurved 
Address  Parul Institute of Ayurved Department of Shalya Tantra 4th floor room no 403 Parul University,Limda.

Vadodara
GUJARAT
391760
India 
Phone  7744066499  
Fax    
Email  dr.nikhilgirase06@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Praikshit Shirode 
Designation  professor 
Affiliation  parul institute of ayurved 
Address  Parul Institute of Ayurved Department of Shalya Tantra 4th floor room no 403 Parul University,Limda,Vadodara, Gujarat.

Vadodara
GUJARAT
391760
India 
Phone  9960063588  
Fax    
Email  parikshit.shirode260038@paruluniversity.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Praikshit Shirode 
Designation  Professor 
Affiliation  Parul Institute of Ayurved 
Address  Parul Institute of Ayurved Department of Shalya Tantra 4th floor room no 403 Parul University,Limda,Vadodara, Gujarat.

Vadodara
GUJARAT
391760
India 
Phone  9960063588  
Fax    
Email  parikshit.shirode260038@paruluniversity.ac.in  
 
Source of Monetary or Material Support  
Parul Institute of Ayurved Department of Shalya Tantra 4th floor room no 403 Parul University,Limda,391760 ,Vadodara, Gujarat,India 
 
Primary Sponsor  
Name  Parul Institute of Ayurved 
Address  Parul Institute of Ayurved Department of Shalya Tantra 4th floor room no 403 Parul University,Limda,Vadodara,Gujrat,India.391760 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikhil Girase  Parul institute of ayurved  parul institute of ayurved department of shalya tantra 4th floor room no 403 parul university limda vadodara gujarat
Vadodara
GUJARAT 
7744066499

dr.nikhilgirase06@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee ,Parul Institute of Ayurved  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:R52||Pain, unspecified. Ayurveda Condition: SULAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-DICLOFENAC TRANSDERMAL PATCH Diclofenac transdermal patch will be applied in nearest muscular area near to the Incision site. Total 15 patients will be included in this group.
2Intervention ArmDrugOther than Classical(1) Medicine Name: vijaya patra transdermal patch, Reference: NA, Route: Topical, Dosage Form: Lepa Churna, Dose: 5(mg), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 5 Days, anupAna/sahapAna: No, Additional Information: Intervention patches will include 1.0 ± 0.1 mg of Cannabidiol in an MCT(medium chain triglyceride) solvent on 2.0 ± 0.2 g of yellow adhesive layer covered with aluminum foil total 15 patients will be included in this group
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients undergone any surgery by Local or spinal anesthesia, complaining of pain, irrespective of their gender & Occupation.
2.Patients who are above 18 years and below 60 years of age.
 
 
ExclusionCriteria 
Details  1.Patients who are regularly taking anti-epileptic, anti-depressant or anti-psychotic drugs & alcohol.
2.Pregnant or breastfeeding mothers.
3.Patients who are taking NSAIDs regularly for other conditions.
4.Patients not giving consent for enrollment in the study.
5.Known allergy to medical cannabis, or patches ingredients, history of severe liver or kidney disease or other serious psychiatric diseases.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Post operative Pain Reduction and sustained analgesic effect of the transdermal patch over time.  from commencement of pain reduction in between 1 hours, 6 hours ,12 hours ,24 hours postoperatively for 5 days post operative days 
 
Secondary Outcome  
Outcome  TimePoints 
the effect on early ambulation and return to daily activities and Assessing ease of use, adherence, and patient preference compared to controlled group medicine  from commencement of pain reduction in between 1 hours, 6 hours ,12 hours ,24 hours postoperatively for 5 days post operative days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Post-operative pain is a significant concern in surgical practice, requiring effective management to enhance recovery and patient comfort. Conventional analgesics, such as opioids and NSAIDs, pose risks of adverse effects and long-term complications. This study aims to evaluate the clinical efficacy and safety of the Vijaya Patra (Cannabis sativa) transdermal patch as an alternative approach for post-operative pain management.

The study will assess pain reduction (VAS scale), opioid/NSAID consumption, duration of analgesia, patient satisfaction, and adverse effects over five days post-surgery. Transdermal drug delivery offers advantages such as sustained release, precise dosing, and reduced systemic side effects. The findings will help establish the potential role of cannabis-based transdermal patches in improving post-operative pain management and reducing reliance on conventional analgesics Given the limited clinical evidence on cannabis-based transdermal patches in post-operative settings, this research will contribute valuable insights into their role as a safe and effective analgesic alternative.

Hence the need and uniqueness of study.

 
Close